The goal of this program is to improve management of non-small cell lung cancer (NSCLC) and metastatic malignant melanoma. After hearing and assimilating this program, the clinician will be better able to: 1. Outline second- and third-line treatment options for nononcogene- driven metastatic NSCLC. 2. Evaluate treatment options for EGFR-mutant NSCLC. 3. Compare PD-1 based therapy with ipilimumab in metastatic melanoma. 4. Minimize adverse events with use of immunotherapy in metastatic melanoma. 5. Optimize use of tumor-infiltrating lymphocyte therapy for metastatic melanoma.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2023-09-27 05:00:00
- End Date: 2023-09-27 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest